drugset / Trial / NCT01358851

LAS41005 in Hyperkeratotic Actinic Keratosis

NCT01358851

Phase 2 Completed 67 enrolled Almirall, S.A.
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to evaluate the efficacy and safety of LAS 41005 compared to cryotherapy in subjects with moderate to severe hyperkeratotic actinic keratosis (punch biopsies).

Timeline

Start
2011-04
Primary completion
2012-03
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Subject fluorouracil Small molecule 0.5 % Topical
Subject salicylic acid Small molecule 10 % Topical

Indications